Vaidya Sane Ayurved Laboratories opened lower at ₹172.50, compared with its previous close of ₹177.00. During today's session, the stock has traded between ₹169.20 and ₹172.50, with an average traded price of ₹171.11. It is currently showing a downward intraday trend.
return calculator
Time Period
An investment of ₹10,000 made 5 years ago in Vaidya Sane Ayurved Laboratories is now worth
₹ 16,129.00
giving a profit of
₹ 6,129.00 (61.29%)
invest now
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
-7.00 (-3.95%)
Day High
₹172.50
Day Low
₹169.20
Day Open
₹172.50
Prev Close
₹177.00
Volume
2,400
Value Traded
₹0.04 Cr
1W Return
-1.96%
1M Return
6.68%
3M Return
-7.56%
6M Return
-15.90%
1Y Return
-37.04%
Fundamentals
Market Cap (₹ Cr.)
179
PE Ratio
20.70
PB Ratio
2.13
Dividend Yield
0.28%
ROE
11.44%
ROCE
15.28%
Book Value (₹)
83.16
Face Value (₹)
10.00
EPS (TTM)
1.12
Industry PE
-
Beta
-
Debt to Equity
-
Investment Returns
1 Week
-1.96%
6 Week
-
1 Month
6.68%
3 Month
-7.56%
9 Month
-31.91%
Financials
Yearly
Consolidated
All values in ₹ crores
1.01
Mar 23
1.01
Mar 24
0.92
Mar 25
1.07
Mar 26
Share Holding Pattern
Promoter66.34%
FII0.00%
DII0.00%
Retails & Others21.10%
Updates
1Jul
Vaidya Sane Ayurved Laboratories secures patent for herbal formulation
Vaidya Sane Ayurved Laboratories has been granted Indian Patent No. 593487 for a method of preparation of herbal formulation. The patent, valid for 20 years from the filing date of 29 November 2019, was granted on 25 June 2026. This move strengthens the company's intellectual property portfolio and competitive positioning in the Ayurvedic sector.
3mo ago
29May
Madhavbaug launches FoodRx to manage lifestyle disorders
Vaidya Sane Ayurved Laboratories Limited (Madhavbaug) has introduced FoodRx, a food intervention system using traditional Indian nutrition to prevent and manage lifestyle disorders like diabetes and heart disease. Based on data from 10 lakh patients, the system focuses on high-protein and high-fibre diets in familiar formats.
4mo ago
21May
Vaidya Sane Ayurved FY26 Net Profit Rises 25.7% to ₹8.99 Cr
Vaidya Sane Ayurved Laboratories Limited reported a 25.7% increase in consolidated net profit to ₹8.99 crore for FY26, while revenue from operations rose 18.9% to ₹106.91 crore. The company approved the acquisition of Parasnath Healthcare for ₹6 crore to strengthen its franchisee clinic operations. Looking ahead, management targets revenue of ₹170 crore to ₹180 crore for FY27 and aims to scale towards ₹250 crore to ₹300 crore by FY28 with EBITDA margins above 20%.
